HEM Pharma Inc. (KOSDAQ:376270)

South Korea flag South Korea · Delayed Price · Currency is KRW
70,000
-2,200 (-3.05%)
At close: Mar 19, 2026
Market Cap502.02B +310.2%
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out7.17M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,585
Average Volume33,056
Open70,500
Previous Close72,200
Day's Range68,600 - 71,400
52-Week Range18,000 - 97,500
Betan/a
RSI46.04
Earnings DateFeb 13, 2026

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376270
Full Company Profile